Concepedia

Changfeng Zhang

CZ

8

Publications

2.5K

Citations

8

H-Index

2016

Active since

Affiliations

University of Pennsylvania(Current)

Parker Institute for Cancer Immunotherapy

Novartis (United States)

First Affiliated Hospital of Soochow University

Children's Hospital of Philadelphia

Changfeng Zhang is an author at University of Pennsylvania specializing in medicine, immunology, and immunotherapy.

ORCID

Top concepts

Publications per year

2016–2022

8

Publications

8

Determinants of response and resistance to CD19 chimeric antigen receptor (CAR) T cell therapy of chronic lymphocytic leukemia

Joseph A. Fraietta, Simon F. Lacey, Elena J. Orlando et al. · Nature Medicine · 2018 · 1.7K citations · Full text

, , +6

Ibrutinib enhances chimeric antigen receptor T-cell engraftment and efficacy in leukemia

Joseph A. Fraietta, Kyle A. Beckwith, Prachi Patel et al. · Blood · 2016 · 450 citations · Full text

Reducing <i>Ex Vivo</i> Culture Improves the Antileukemic Activity of Chimeric Antigen Receptor (CAR) T Cells

Saba Ghassemi, Selene Nuñez-Cruz, Roddy S. O’Connor et al. · Cancer Immunology Research · 2018 · 286 citations · Full text

Evaluation of Antioxidant Capacity and Gut Microbiota Modulatory Effects of Different Kinds of Berries

Jiebiao Chen, Yichen Shu, Yanhong Chen et al. · Antioxidants · 2022 · 45 citations · Full text

, , +14

Comparison of CAR-T19 and autologous stem cell transplantation for refractory/relapsed non-Hodgkin’s lymphoma

Caixia Li, Ying Zhang, Changfeng Zhang et al. · JCI Insight · 2019 · 27 citations · Full text

Rows per page

1–5 of 8